ERYTECH announces ADR Level 1 listing in the US Post author:admERY Post published:January 12, 2015 Post category:Newsroom ERYTECH today announced the launch of a sponsored American Depository Receipt (ADR) Level 1 listing in the United States in order to support the expansion of the Company’s US investor base. You Might Also Like ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018 ERYTECH announces positive safety review for eryaspase in its Phase 2 study in pancreatic cancer July 20, 2015 REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 June 24, 2022
ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018
ERYTECH announces positive safety review for eryaspase in its Phase 2 study in pancreatic cancer July 20, 2015